Thyroid hormone receptor-beta drugs for MASH / NASH

3 tracked Thyroid hormone receptor-beta drugs in the MASH / NASH race. The class explanation lives on the Thyroid hormone receptor-beta page; the full indication pipeline across every mechanism is on the MASH / NASH page.

1 approved / phase 42 Phase 2

Head-to-head evidence: ALG-055009 vs Resmetirom · ALG-055009 vs VK2809 · Resmetirom vs VK2809

The roster

← all Thyroid hormone receptor-beta drugs